 |
|
|
|
|
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Pochet R. on NEWS: ALS—Is It the Neurons or the Glia?, The Science article by Clement (Don Cleveland, University of California) and other US and... 6 Oct 2003.
|
|
|
 |
|
|
Pochet R. on PAPER: Ciavarro GL. et al., 2003, Seems interesting. 23 Sep 2003.
|
|
|
|
|
|
Pochet R. on NEWS: Calbindin Study: Is Calcium the Molecular Handle on Dysfunction in AD?, I would like to stress that already in 1993, Sutherland MK, Wong L, Somerville MJ, Yoong LK,... 3 Aug 2003.
|
|
|
|
|
|
Pochet R. on PAPER: Parvizi J. et al., 2003, Calbindin and parvalbumin were until now both classified as intracellular calcium buffers and... 23 Jun 2003.
|
|
|
|
|
|
Pochet R. on PAPER: Takeda A. et al., 2003, The zinc-deficient rat might be useful to study zinc homeostasis within Alzheimer's and ALS rat... 23 Jun 2003.
|
|
|
|
|
|
Pochet R. on PAPER: Ribeiro JA. et al., 2003, Adenosine receptors are regulating many "cell behaviors" and deserve much attention by drug... 23 Jun 2003.
|
|
|
|
|
|
Pochet R. on NEWS: Is SOD's Contribution to Lou Gehrig’s Disease Unfolding?, The concept of mutated SOD1 aggregate formation was previously evoked, but this article gives... 9 Jun 2003.
|
|
|
|
|
|
Pochet R. on PAPER: Strange RW. et al., 2003, Study of the 3D structure of Cu/Zn SOD1 wild type and its comparison with mutated forms is... 20 May 2003.
|
|
|
|
|
|
Pochet R. on PAPER: Takahashi Y. et al., 2003, Drug discovery within the field of neuroinflammation is a research orientation which should be... 1 Apr 2003.
|
|
|
|
|
|
Pochet R. on PAPER: Stanford PM. et al., 2003, This a supplementary evidence that neuroinflammation is an actor in neurodegenerative diseases... 24 Mar 2003.
|
|
|
|
|
|
Pochet R. on PAPER: Petrella JR. et al., 2003, This paper should have a broad impact on clinicians and promote neuroimaging 23 Feb 2003.
|
|
|
|
|
|
|
1 to 11 of 11 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our most recent Webinar: 
